glp-1 receptor agonist side effects Safety and Tolerability of Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs Peptide/GLP-1 Complications: 11 Hidden Risks
Description
Regarding the secondary endpoint hospitalization due to heart failure, the results of the studies are heterogenous
J Nephrol 33 , 965975 (2020)
As with any new medication, there is more to learn to ensure patients are set up for success
62 Table 4
Understanding GLP-1 dosing: Starting low and titrating up All GLP-1 medications (glucagon-like peptide-1 receptor agonists) are initiated at a low dose and their dosage is gradually escalated over time to enhance your bodys tolerability and minimize the risk of side effects, particularly gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
